NDAQ:AGEN - Post Discussion
Agenus Inc
> Agenus to Participate in Oppenheimer 34th Annual Healthcare
Post by
whytestocks on Jan 31, 2024 12:15pm
Agenus to Participate in Oppenheimer 34th Annual Healthcare
Breaking News: $AGEN Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences ConferenceAgenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that Dr. Garo Armen, Chairman and CEO, will participate in a fireside chat and investor one-on-ones at the upcoming Oppenheimer Healthca...
AGEN - Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
Be the first to comment on this post